373 related articles for article (PubMed ID: 25349983)
1. Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists.
Ng HW; Zhang W; Shu M; Luo H; Ge W; Perkins R; Tong W; Hong H
BMC Bioinformatics; 2014; 15 Suppl 11(Suppl 11):S4. PubMed ID: 25349983
[TBL] [Abstract][Full Text] [Related]
2. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.
Zhang L; Sedykh A; Tripathi A; Zhu H; Afantitis A; Mouchlis VD; Melagraki G; Rusyn I; Tropsha A
Toxicol Appl Pharmacol; 2013 Oct; 272(1):67-76. PubMed ID: 23707773
[TBL] [Abstract][Full Text] [Related]
3. Exploration of endocrine-disrupting chemicals on estrogen receptor alpha by the agonist/antagonist differential-docking screening (AADS) method: 4-(1-adamantyl)phenol as a potent endocrine disruptor candidate.
Nose T; Tokunaga T; Shimohigashi Y
Toxicol Lett; 2009 Dec; 191(1):33-9. PubMed ID: 19666091
[TBL] [Abstract][Full Text] [Related]
4. Predicting Potential Endocrine Disrupting Chemicals Binding to Estrogen Receptor α (ERα) Using a Pipeline Combining Structure-Based and Ligand-Based in Silico Methods.
Sellami A; Montes M; Lagarde N
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799614
[TBL] [Abstract][Full Text] [Related]
5. In silico identification and pharmacological evaluation of novel endocrine disrupting chemicals that act via the ligand-binding domain of the estrogen receptor α.
McRobb FM; Kufareva I; Abagyan R
Toxicol Sci; 2014 Sep; 141(1):188-97. PubMed ID: 24928891
[TBL] [Abstract][Full Text] [Related]
6. Exploring interactions of endocrine-disrupting compounds with different conformations of the human estrogen receptor alpha ligand binding domain: a molecular docking study.
Celik L; Davey J; Lund D; Schiøtt B
Chem Res Toxicol; 2008 Nov; 21(11):2195-206. PubMed ID: 18921983
[TBL] [Abstract][Full Text] [Related]
7. Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists.
Lee S; Barron MG
PLoS One; 2017; 12(1):e0169607. PubMed ID: 28061508
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of Agonist and Antagonist Dynamic Binding Patterns in ER-α by Integration of Molecular Docking, Molecular Dynamics Simulations and Quantum Mechanical Calculations.
Sakkiah S; Selvaraj C; Guo W; Liu J; Ge W; Patterson TA; Hong H
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502280
[TBL] [Abstract][Full Text] [Related]
9. Estimation of competitive antagonist affinity by the Schild method and from functional inhibition curves using a novel form of the Gaddum equation.
Ezechiáš M; Cajthaml T
Toxicology; 2019 May; 420():21-28. PubMed ID: 30935971
[TBL] [Abstract][Full Text] [Related]
10. Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein.
Hong H; Branham WS; Ng HW; Moland CL; Dial SL; Fang H; Perkins R; Sheehan D; Tong W
Toxicol Sci; 2015 Feb; 143(2):333-48. PubMed ID: 25349334
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided identification of novel protein targets of bisphenol A.
Montes-Grajales D; Olivero-Verbel J
Toxicol Lett; 2013 Oct; 222(3):312-20. PubMed ID: 23973438
[TBL] [Abstract][Full Text] [Related]
12. Exploring the binding features of polybrominated diphenyl ethers as estrogen receptor antagonists: docking studies.
Yang WH; Wang ZY; Liu HL; Yu HX
SAR QSAR Environ Res; 2010 Apr; 21(3-4):351-67. PubMed ID: 20544555
[TBL] [Abstract][Full Text] [Related]
13. Structural insights into selective agonist actions of tamoxifen on human estrogen receptor alpha.
Chakraborty S; Biswas PK
J Mol Model; 2014 Aug; 20(8):2338. PubMed ID: 25060147
[TBL] [Abstract][Full Text] [Related]
14. Determination and analysis of agonist and antagonist potential of naturally occurring flavonoids for estrogen receptor (ERα) by various parameters and molecular modelling approach.
Puranik NV; Srivastava P; Bhatt G; John Mary DJS; Limaye AM; Sivaraman J
Sci Rep; 2019 May; 9(1):7450. PubMed ID: 31092862
[TBL] [Abstract][Full Text] [Related]
15. Elucidating Binding Sites and Affinities of ERα Agonists and Antagonists to Human Alpha-Fetoprotein by In Silico Modeling and Point Mutagenesis.
Moldogazieva NT; Ostroverkhova DS; Kuzmich NN; Kadochnikov VV; Terentiev AA; Porozov YB
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019136
[TBL] [Abstract][Full Text] [Related]
16. Selected polychlorobiphenyls congeners bind to estrogen receptor alpha in human umbilical vascular endothelial (HUVE) cells modulating angiogenesis.
Tavolari S; Bucci L; Tomasi V; Guarnieri T
Toxicology; 2006 Jan; 218(1):67-74. PubMed ID: 16293362
[TBL] [Abstract][Full Text] [Related]
17. In silico prediction and in vivo analysis of antiestrogenic potential of 2-isopropylthioxanthone (2-ITX) in juvenile goldfish (Carassius auratus).
Cocci P; Mozzicafreddo M; Angeletti M; Mosconi G; Palermo FA
Ecotoxicol Environ Saf; 2016 Nov; 133():202-10. PubMed ID: 27454205
[TBL] [Abstract][Full Text] [Related]
18. Molecular interactions of vinclozolin metabolites with human estrogen receptors 1GWR-α and 1QKM and androgen receptor 2AM9-β: Implication for endocrine disruption.
Habib H; Haider MR; Sharma S; Ahmad S; Dabeer S; Yar MS; Raisuddin S
Toxicol Mech Methods; 2020 Jun; 30(5):370-377. PubMed ID: 32208804
[No Abstract] [Full Text] [Related]
19. Molecular docking, molecular dynamics simulation, and structure-based 3D-QSAR studies on estrogenic activity of hydroxylated polychlorinated biphenyls.
Li X; Ye L; Wang X; Wang X; Liu H; Qian X; Zhu Y; Yu H
Sci Total Environ; 2012 Dec; 441():230-8. PubMed ID: 23137989
[TBL] [Abstract][Full Text] [Related]
20. Identification of active and inactive agonists/antagonists of estrogen receptor based on Tox21 10K compound library: Binomial analysis and structure alert.
Wang J; Huang Y; Wang S; Yang Y; He J; Li C; Zhao YH; Martyniuk CJ
Ecotoxicol Environ Saf; 2021 May; 214():112114. PubMed ID: 33711575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
